Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
Acta Oncologica (Stockholm, Sweden)
|
February 9, 2000
Induction chemotherapy followed by concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancer
E H Tan, J Wee, P T Ang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 19, 2005
Randomized study of vinorelbine--gemcitabine versus vinorelbine--carboplatin in patients with advanced non-small cell lung cancer
E H Tan, A Szczesna, M Krzakowski, et al.
Bone Marrow Transplantation
|
July 28, 2010
Graft-vs-tumor effect in patients with advanced nasopharyngeal cancer treated with nonmyeloablative allogeneic PBSC transplantation
H C Toh, W K Chia, L Sun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2011
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer
C Manegold, N van Zandwijk, A Szczesna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 27, 1999
Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma
E H Tan, K S Khoo, J Wee, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 19, 1999
Concurrent chemoradiotherapy followed by adjuvant chemotherapy in Asian patients with nasopharyngeal carcinoma: toxicities and preliminary results
E H Tan, E T Chua, J Wee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 30, 2010
A multicentre phase II gene expression profiling study of putative relationships between tumour biomarkers and clinical response with erlotinib in non-small-cell lung cancer
E-H Tan, R Ramlau, A Pluzanska, et al.
Respiratory Medicine
|
July 12, 2003
A multicenter phase II study of the efficacy and safety of docetaxel plus cisplatin in Asian chemonaïve patients with metastatic or locally advanced non-small cell lung cancer
James C M Ho, E H Tan, S S Leong, et al.
Plos One
|
March 6, 2008
Nonvirally modified autologous primary hepatocytes correct diabetes and prevent target organ injury in a large preclinical model
Nelson K F Chen, Jen San Wong, Irene H C Kee, et al.
Investigational New Drugs
|
June 19, 2015
Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079)
B B Y Ma, B C Goh, W T Lim, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
Acta Oncologica (Stockholm, Sweden)
|
February 9, 2000
Induction chemotherapy followed by concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancer
E H Tan, J Wee, P T Ang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 19, 2005
Randomized study of vinorelbine--gemcitabine versus vinorelbine--carboplatin in patients with advanced non-small cell lung cancer
E H Tan, A Szczesna, M Krzakowski, et al.
Bone Marrow Transplantation
|
July 28, 2010
Graft-vs-tumor effect in patients with advanced nasopharyngeal cancer treated with nonmyeloablative allogeneic PBSC transplantation
H C Toh, W K Chia, L Sun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2011
A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer
C Manegold, N van Zandwijk, A Szczesna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 27, 1999
Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma
E H Tan, K S Khoo, J Wee, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 19, 1999
Concurrent chemoradiotherapy followed by adjuvant chemotherapy in Asian patients with nasopharyngeal carcinoma: toxicities and preliminary results
E H Tan, E T Chua, J Wee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 30, 2010
A multicentre phase II gene expression profiling study of putative relationships between tumour biomarkers and clinical response with erlotinib in non-small-cell lung cancer
E-H Tan, R Ramlau, A Pluzanska, et al.
Respiratory Medicine
|
July 12, 2003
A multicenter phase II study of the efficacy and safety of docetaxel plus cisplatin in Asian chemonaïve patients with metastatic or locally advanced non-small cell lung cancer
James C M Ho, E H Tan, S S Leong, et al.
Plos One
|
March 6, 2008
Nonvirally modified autologous primary hepatocytes correct diabetes and prevent target organ injury in a large preclinical model
Nelson K F Chen, Jen San Wong, Irene H C Kee, et al.
Investigational New Drugs
|
June 19, 2015
Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079)
B B Y Ma, B C Goh, W T Lim, et al.
Page
of 8